This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Mabxience S.A.
Mabxience S.A., headquartered in Switzerland, is a prominent player in the biopharmaceutical industry, specialising in the development and manufacturing of biosimilars and innovative biologics. Founded in 2015, the company has rapidly established itself in key operational regions across Europe and Latin America, focusing on enhancing patient access to high-quality therapies. Mabxience's core offerings include a range of biosimilars that are distinguished by their rigorous quality standards and commitment to affordability. The company has achieved significant milestones, including successful product launches and partnerships that bolster its market position. With a dedication to research and development, Mabxience continues to contribute to the evolving landscape of biopharmaceuticals, ensuring that patients receive effective and accessible treatment options.
DitchCarbon Score
How does Mabxience S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mabxience S.A.'s score of 6 is lower than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mabxience S.A., headquartered in Switzerland (CH), currently does not have specific carbon emissions data available for recent years, as indicated by the absence of emissions figures. The company is a current subsidiary of Insud Pharma S.L.U., which may influence its climate commitments and performance metrics. As of now, Mabxience S.A. has not established any documented reduction targets or climate pledges, nor does it report any initiatives under the Science Based Targets initiative (SBTi) or other climate frameworks. This lack of specific data suggests that the company may still be in the early stages of developing its climate strategy or reporting practices. Given the absence of direct emissions data and reduction initiatives, it is essential for Mabxience S.A. to consider setting measurable targets and engaging in climate action to align with industry standards and expectations. This would not only enhance their sustainability profile but also contribute positively to global climate efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 521,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,013,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mabxience S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
